• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVIDIA HEALTH, INC. TFOCUS; BLOOD GLUCOSE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVIDIA HEALTH, INC. TFOCUS; BLOOD GLUCOSE SYSTEM Back to Search Results
Model Number TFOCUS
Medical Device Problem Codes Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457); Low Test Results (2458)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 03/28/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(manufacturer narrative = t, corrected data = f) internal report # (b)(4).Product not returned for evaluation.No replacement due to customer going directly to the pharmacy.Most likely underlying root cause: mlc-55 - user had an inaccurate reference: competitor's meter: the end user is comparing results obtained from trividia's bgm system to the results from a competitor's bgm system.Test strip udi#: (b)(4).Note: manufacturer contacted customer (several attempts) in a follow-up call to ensure that the initial concern is resolved - unable to establish contact at this time.Product notification letter sent to contact customer care.
 
Event or Problem Description
Consumer reported complaint for lo, high and erratic blood glucose test results.The customer is concerned with tests results from results obtained of lo, 112, 165, 167 and 151 mg/dl.Customer was also comparing meter to three other meters.Actual meter to meter comparison results were not provided.Customer stated that he would not eat from the evening to the next morning and would still get results over 120 mg/dl.The customer's expected fasting blood glucose test result range is 80 - 110 mg/dl.The customer feels well and did not report any symptoms.Medical attention is not reported as a result of the actual blood glucose results.During the call a back to back blood test was performed by the customer fasting and produced test results of 146 mg/dl and 135 mg/dl using meter.The product is stored according to specification in the bedroom.The test strip lot manufacturer's expiration date is 08/29/2020 and open vial date is 02/2019.The meter memory was reviewed for previous test result history: result 1: lo 845 (b)(6) fasting.Result 2: 112mg/dl (b)(6) 528p fasting.Result 3: 165mg/dl 11:00 (b)(6) fasting.Result 4: 167mg/dl 1058a (b)(6) fasting.Result 5: 151 8:47a (b)(6) fasting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TFOCUS
Common Device Name
BLOOD GLUCOSE SYSTEM
Manufacturer (Section D)
TRIVIDIA HEALTH, INC.
2400 nw 55th court
fort lauderdale FL 33309
MDR Report Key8540586
Report Number1000113657-2019-00375
Device Sequence Number16580403
Product Code NBW
UDI-Device Identifier00021292007744
UDI-Public(01)00021292007744
Combination Product (Y/N)N
PMA/510(K) Number
K131013
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Other
Remedial Action Other
Type of Report Initial
Report Date (Section B) 04/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date08/29/2020
Device Model NumberTFOCUS
Device Lot NumberNV1000
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Event Location Home
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/28/2019
Initial Report FDA Received Date04/23/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-